{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:11:58Z","timestamp":1791277918810,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2013,8,16]],"date-time":"2013-08-16T00:00:00Z","timestamp":1376611200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Cancer Journal"],"DOI":"10.1038\/bcj.2013.36","type":"journal-article","created":{"date-parts":[[2013,8,16]],"date-time":"2013-08-16T13:16:26Z","timestamp":1376658986000},"page":"e135-e135","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Loss of the xeroderma pigmentosum group B protein binding site impairs p210 BCR\/ABL1 leukemogenic activity"],"prefix":"10.1038","volume":"3","author":[{"given":"N L","family":"Pannucci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Sahay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E K","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Tala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B T","family":"Ciccarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N J","family":"Megjugorac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H C","family":"Adams III","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P L","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E R","family":"Fitzpatrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Lagunoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D A","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I P","family":"Whitehead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,8,16]]},"reference":[{"key":"BFbcj201336_CR1","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood.V88.7.2375.bloodjournal8872375","volume":"88","author":"JV Melo","year":"1996","unstructured":"Melo JV . The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype. Blood 1996; 88: 2375\u20132384.","journal-title":"Blood"},{"key":"BFbcj201336_CR2","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1128\/MCB.11.4.1785","volume":"11","author":"AJ Muller","year":"1991","unstructured":"Muller AJ, Young JC, Pendergast AM, Pondel M, Landau NR, Littman DR et al. BCR first exon sequences specifically activate the BCR\/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias. Mol Cell Biol 1991; 11: 1785\u20131792.","journal-title":"Mol Cell Biol"},{"key":"BFbcj201336_CR3","doi-asserted-by":"publisher","first-page":"7587","DOI":"10.1128\/MCB.13.12.7587","volume":"13","author":"JR McWhirter","year":"1993","unstructured":"McWhirter JR, Galasso DL, Wang JY . A coiled-coil oligomerization domain of Bcr is essential for the transforming function of Bcr-Abl oncoproteins. Mol Cell Biol 1993; 13: 7587\u20137595.","journal-title":"Mol Cell Biol"},{"key":"BFbcj201336_CR4","doi-asserted-by":"publisher","first-page":"15353","DOI":"10.1074\/jbc.271.26.15353","volume":"271","author":"Y Maru","year":"1996","unstructured":"Maru Y, Afar DE, Witte ON, Shibuya M . The dimerization property of glutathione S-transferase partially reactivates Bcr-Abl lacking the oligomerization domain. J Biol Chem 1996; 271: 15353\u201315357.","journal-title":"J Biol Chem"},{"key":"BFbcj201336_CR5","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0092-8674(05)80094-7","volume":"75","author":"AM Pendergast","year":"1993","unstructured":"Pendergast AM, Quilliam LA, Cripe LD, Bassing CH, Dai Z, Li N et al. BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein. Cell 1993; 75: 175\u2013185.","journal-title":"Cell"},{"key":"BFbcj201336_CR6","doi-asserted-by":"publisher","first-page":"4010","DOI":"10.1182\/blood-2003-12-4111","volume":"103","author":"B Calabretta","year":"2004","unstructured":"Calabretta B, Perrotti D . The biology of CML blast crisis. Blood 2004; 103: 4010\u20134022.","journal-title":"Blood"},{"key":"BFbcj201336_CR7","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S1535-6108(04)00056-X","volume":"5","author":"J Dierov","year":"2004","unstructured":"Dierov J, Dierova R, Carroll M . BCR\/ABL translocates to the nucleus and disrupts an ATR-dependent intra-S phase checkpoint. Cancer cell 2004; 5: 275\u2013285.","journal-title":"Cancer cell"},{"key":"BFbcj201336_CR8","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1080\/03093640701859089","volume":"49","author":"T Skorski","year":"2008","unstructured":"Skorski T . BCR\/ABL, DNA damage and DNA repair: implications for new treatment concepts. Leuk Lymphoma 2008; 49: 610\u2013614.","journal-title":"Leuk Lymphoma"},{"key":"BFbcj201336_CR9","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1182\/blood.V86.3.1148.1148","volume":"86","author":"A Bedi","year":"1995","unstructured":"Bedi A, Barber JP, Bedi GC, el-Deiry WS, Sidransky D, Vala MS et al. BCR-ABL-mediated inhibition of apoptosis with delay of G2\/M transition after DNA damage: a mechanism of resistance to multiple anticancer agents. Blood 1995; 86: 1148\u20131158.","journal-title":"Blood"},{"key":"BFbcj201336_CR10","first-page":"463","volume":"55","author":"EJ Fuchs","year":"1995","unstructured":"Fuchs EJ, Bedi A, Jones RJ, Hess AD . Cytotoxic T cells overcome BCR-ABL-mediated resistance to apoptosis. Cancer Res 1995; 55: 463\u2013466.","journal-title":"Cancer Res"},{"key":"BFbcj201336_CR11","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0304-3835(00)00569-3","volume":"160","author":"KT Papazisis","year":"2000","unstructured":"Papazisis KT, Zambouli D, Kimoundri OT, Papadakis ES, Vala V, Geromichalos GD et al. Protein tyrosine kinase inhibitor, genistein, enhances apoptosis and cell cycle arrest in K562 cells treated with gamma-irradiation. Cancer Lett 2000; 160: 107\u2013113.","journal-title":"Cancer Lett"},{"key":"BFbcj201336_CR12","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S1097-2765(01)00357-4","volume":"8","author":"A Slupianek","year":"2001","unstructured":"Slupianek A, Schmutte C, Tombline G, Nieborowska-Skorska M, Hoser G, Nowicki MO et al. BCR\/ABL regulates mammalian RecA homologs, resulting in drug resistance. Mol Cell 2001; 8: 795\u2013806.","journal-title":"Mol Cell"},{"key":"BFbcj201336_CR13","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1182\/blood.V98.5.1532","volume":"98","author":"H van der Kuip","year":"2001","unstructured":"van der Kuip H, Goetz AW, Miething C, Duyster J, Aulitzky WE . Adhesion to fibronectin selectively protects Bcr-Abl+ cells from DNA damage-induced apoptosis. Blood 2001; 98: 1532\u20131541.","journal-title":"Blood"},{"key":"BFbcj201336_CR14","doi-asserted-by":"publisher","first-page":"4189","DOI":"10.1128\/MCB.22.12.4189-4201.2002","volume":"22","author":"A Slupianek","year":"2002","unstructured":"Slupianek A, Hoser G, Majsterek I, Bronisz A, Malecki M, Blasiak J et al. Fusion tyrosine kinases induce drug resistance by stimulation of homology-dependent recombination repair, prolongation of G(2)\/M phase, and protection from apoptosis. Mol Cell Biol 2002; 22: 4189\u20134201.","journal-title":"Mol Cell Biol"},{"key":"BFbcj201336_CR15","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1182\/blood-2002-10-3207","volume":"102","author":"Y Canitrot","year":"2003","unstructured":"Canitrot Y, Falinski R, Louat T, Laurent G, Cazaux C, Hoffmann JS et al. p210 BCR\/ABL kinase regulates nucleotide excision repair (NER) and resistance to UV radiation. Blood 2003; 102: 2632\u20132637.","journal-title":"Blood"},{"issue":"10 Pt 1","key":"BFbcj201336_CR16","first-page":"3722","volume":"9","author":"E Laurent","year":"2003","unstructured":"Laurent E, Mitchell DL, Estrov Z, Lowery M, Tucker SL, Talpaz M et al. Impact of p210(Bcr-Abl) on ultraviolet C wavelength-induced DNA damage and repair. Clin Cancer Res 2003; 9 (10 Pt 1): 3722\u20133730.","journal-title":"Clin Cancer Res"},{"key":"BFbcj201336_CR17","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/cr.2008.2","volume":"18","author":"SC Shuck","year":"2008","unstructured":"Shuck SC, Short EA, Turchi JJ . Eukaryotic nucleotide excision repair: from understanding mechanisms to influencing biology. Cell Res 2008; 18: 64\u201372.","journal-title":"Cell Res"},{"key":"BFbcj201336_CR18","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1006\/bbrc.1999.0822","volume":"260","author":"Y Maru","year":"1999","unstructured":"Maru Y, Kobayashi T, Tanaka K, Shibuya M . BCR binds to the xeroderma pigmentosum group B protein. Biochem Biophys Res Commun 1999; 260: 309\u2013312.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFbcj201336_CR19","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1073\/pnas.96.1.203","volume":"96","author":"N Takeda","year":"1999","unstructured":"Takeda N, Shibuya M, Maru Y . The BCR-ABL oncoprotein potentially interacts with the xeroderma pigmentosum group B protein. Proc Natl Acad Sci USA 1999; 96: 203\u2013207.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFbcj201336_CR20","doi-asserted-by":"crossref","first-page":"9826","DOI":"10.1016\/S0021-9258(17)36958-2","volume":"269","author":"R Roy","year":"1994","unstructured":"Roy R, Schaeffer L, Humbert S, Vermeulen W, Weeda G, Egly JM . The DNA-dependent ATPase activity associated with the class II basic transcription factor BTF2\/TFIIH. J Biol Chem 1994; 269: 9826\u20139832.","journal-title":"J Biol Chem"},{"key":"BFbcj201336_CR21","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1126\/science.8465201","volume":"260","author":"L Schaeffer","year":"1993","unstructured":"Schaeffer L, Roy R, Humbert S, Moncollin V, Vermeulen W, Hoeijmakers JH et al. DNA repair helicase: a component of BTF2 (TFIIH) basic transcription factor. Science 1993; 260: 58\u201363.","journal-title":"Science"},{"key":"BFbcj201336_CR22","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1002\/j.1460-2075.1994.tb06428.x","volume":"13","author":"AJ van Vuuren","year":"1994","unstructured":"van Vuuren AJ, Vermeulen W, Ma L, Weeda G, Appeldoorn E, Jaspers NG et al. Correction of xeroderma pigmentosum repair defect by basal transcription factor BTF2 (TFIIH). EMBO J 1994; 13: 1645\u20131653.","journal-title":"EMBO J"},{"key":"BFbcj201336_CR23","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1038\/sj.onc.1210841","volume":"27","author":"S Sahay","year":"2008","unstructured":"Sahay S, Pannucci NL, Mahon GM, Rodriguez PL, Megjugorac NJ, Kostenko EV et al. The RhoGEF domain of p210 Bcr-Abl activates RhoA and is required for transformation. Oncogene 2008; 27: 2064\u20132071.","journal-title":"Oncogene"},{"key":"BFbcj201336_CR24","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S0960-9822(03)00090-3","volume":"13","author":"GM Mahon","year":"2003","unstructured":"Mahon GM, Wang Y, Korus M, Kostenko E, Cheng L, Sun T et al. The c-Myc Oncoprotein Interacts with Bcr. Curr Biol 2003; 13: 437\u2013441.","journal-title":"Curr Biol"},{"key":"BFbcj201336_CR25","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S1074-7613(00)80103-X","volume":"11","author":"L Van Parijs","year":"1999","unstructured":"Van Parijs L, Refaeli Y, Lord JD, Nelson BH, Abbas AK, Baltimore D . Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation-induced cell death. Immunity 1999; 11: 281\u2013288.","journal-title":"Immunity"},{"key":"BFbcj201336_CR26","doi-asserted-by":"crossref","first-page":"5701","DOI":"10.1128\/jvi.70.8.5701-5705.1996","volume":"70","author":"RK Naviaux","year":"1996","unstructured":"Naviaux RK, Costanzi E, Haas M, Verma IM . The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses. J Virol 1996; 70: 5701\u20135705.","journal-title":"J Virol"},{"issue":"5","key":"BFbcj201336_CR27","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1038\/leu.2012.351","volume":"27","author":"I Tala","year":"2012","unstructured":"Tala I, Chen R, Hu T, Fitzpatrick ER, Williams DA, Whitehead IP . Contributions of the RhoGEF activity of p210 BCR\/ABL to disease progression. Leukemia 27: 1080\u20131089.","journal-title":"Leukemia"},{"key":"BFbcj201336_CR28","doi-asserted-by":"publisher","first-page":"6250","DOI":"10.1158\/0008-5472.CAN-06-0536","volume":"66","author":"OO Olabisi","year":"2006","unstructured":"Olabisi OO, Mahon GM, Kostenko EV, Liu Z, Ozer HL, Whitehead IP . Bcr interacts with components of the endosomal sorting complex required for transport-I and is required for epidermal growth factor receptor turnover. Cancer Res 2006; 66: 6250\u20136257.","journal-title":"Cancer Res"},{"key":"BFbcj201336_CR29","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1182\/blood.V84.6.1731.1731","volume":"84","author":"J ten Hoeve","year":"1994","unstructured":"ten Hoeve J, Arlinghaus RB, Guo JQ, Heisterkamp N, Groffen J . Tyrosine phosphorylation of CRKL in Philadelphia+ leukemia. Blood 1994; 84: 1731\u20131736.","journal-title":"Blood"},{"issue":"Suppl 1","key":"BFbcj201336_CR30","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3109\/10428199309047862","volume":"11","author":"CL Sawyers","year":"1993","unstructured":"Sawyers CL . The role of myc in transformation by BCR-ABL. Leuk Lymphoma 1993; 11 (Suppl 1): 45\u201346.","journal-title":"Leuk Lymphoma"},{"key":"BFbcj201336_CR31","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/0092-8674(92)90241-4","volume":"70","author":"CL Sawyers","year":"1992","unstructured":"Sawyers CL, Callahan W, Witte ON . Dominant negative MYC blocks transformation by ABL oncogenes. Cell 1992; 70: 901\u2013910.","journal-title":"Cell"},{"key":"BFbcj201336_CR32","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1038\/sj.emboj.7601101","volume":"25","author":"J Liu","year":"2006","unstructured":"Liu J, Kouzine F, Nie Z, Chung HJ, Elisha-Feil Z, Weber A et al. The FUSE\/FBP\/FIR\/TFIIH system is a molecular machine programming a pulse of c-myc expression. EMBO J 2006; 25: 2119\u20132130.","journal-title":"EMBO J"},{"key":"BFbcj201336_CR33","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1128\/MCB.25.1.147-161.2005","volume":"25","author":"A Weber","year":"2005","unstructured":"Weber A, Liu J, Collins I, Levens D . TFIIH operates through an expanded proximal promoter to fine-tune c-myc expression. Mol Cell Biol 2005; 25: 147\u2013161.","journal-title":"Mol Cell Biol"},{"key":"BFbcj201336_CR34","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1084\/jem.189.9.1399","volume":"189","author":"S Li","year":"1999","unstructured":"Li S, Ilaria RL Jr, Million RP, Daley GQ, Van Etten RA . The P190, P210, and P230 forms of the BCR\/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity. J Exp Med 1999; 189: 1399\u20131412.","journal-title":"J Exp Med"},{"key":"BFbcj201336_CR35","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1182\/blood.V92.10.3780","volume":"92","author":"WS Pear","year":"1998","unstructured":"Pear WS, Miller JP, Xu L, Pui JC, Soffer B, Quackenbush RC et al. Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr\/abl-transduced bone marrow. Blood 1998; 92: 3780\u20133792.","journal-title":"Blood"},{"key":"BFbcj201336_CR36","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1182\/blood.V92.10.3829.422k14_3829_3840","volume":"92","author":"X Zhang","year":"1998","unstructured":"Zhang X, Ren R . Bcr-Abl efficiently induces a myeloproliferative disease and production of excess interleukin-3 and granulocyte-macrophage colony-stimulating factor in mice: a novel model for chronic myelogenous leukemia. Blood 1998; 92: 3829\u20133840.","journal-title":"Blood"},{"key":"BFbcj201336_CR37","first-page":"1499","volume":"9","author":"MJ Stewart","year":"1995","unstructured":"Stewart MJ, Litz-Jackson S, Burgess GS, Williamson EA, Leibowitz DS, Boswell HS . Role for E2F1 in p210 BCR-ABL downstream regulation of c-myc transcription initiation. Studies in murine myeloid cells. Leukemia 1995; 9: 1499\u20131507.","journal-title":"Leukemia"},{"key":"BFbcj201336_CR38","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1182\/blood.V96.6.2269","volume":"96","author":"F Gesbert","year":"2000","unstructured":"Gesbert F, Griffin JD . Bcr\/Abl activates transcription of the Bcl-X gene through STAT5. Blood 2000; 96: 2269\u20132276.","journal-title":"Blood"},{"key":"BFbcj201336_CR39","doi-asserted-by":"publisher","first-page":"9400","DOI":"10.1074\/jbc.M312840200","volume":"279","author":"WC Gustafson","year":"2004","unstructured":"Gustafson WC, Ray S, Jamieson L, Thompson EA, Brasier AR, Fields AP . Bcr-Abl regulates protein kinase Ciota (PKCiota) transcription via an Elk1 site in the PKCiota promoter. J Biol Chem 2004; 279: 9400\u20139408.","journal-title":"J Biol Chem"},{"key":"BFbcj201336_CR40","doi-asserted-by":"publisher","first-page":"6523","DOI":"10.1073\/pnas.0731871100","volume":"100","author":"S Ghaffari","year":"2003","unstructured":"Ghaffari S, Jagani Z, Kitidis C, Lodish HF, Khosravi-Far R . Cytokines and BCR-ABL mediate suppression of TRAIL-induced apoptosis through inhibition of forkhead FOXO3a transcription factor. Proc Natl Acad Sci USA 2003; 100: 6523\u20136528.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFbcj201336_CR41","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/j.1600-0609.2006.00629.x","volume":"76","author":"FB Hickey","year":"2006","unstructured":"Hickey FB, Cotter TG . Identification of transcriptional targets associated with the expression of p210 Bcr-Abl. Eur J Haematol 2006; 76: 369\u2013383.","journal-title":"Eur J Haematol"},{"key":"BFbcj201336_CR42","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S1097-2765(00)80428-1","volume":"5","author":"J Liu","year":"2000","unstructured":"Liu J, He L, Collins I, Ge H, Libutti D, Li J et al. The FBP interacting repressor targets TFIIH to inhibit activated transcription. Mol Cell 2000; 5: 331\u2013341.","journal-title":"Mol Cell"}],"container-title":["Blood Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/bcj201336.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bcj201336","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bcj201336.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T22:48:56Z","timestamp":1672958936000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bcj201336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,16]]},"references-count":42,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2013,8]]}},"alternative-id":["BFbcj201336"],"URL":"https:\/\/doi.org\/10.1038\/bcj.2013.36","relation":{},"ISSN":["2044-5385"],"issn-type":[{"value":"2044-5385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,16]]},"assertion":[{"value":"11 February 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2013","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2013","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2013","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}